Cell Response to 5-Fluorouracil in Resistant Colon Cancer Cells
Author Information
Author(s): Paula M De Angelis, Debbie H Svendsrud, Katherine L Kravik, Trond Stokke
Primary Institution: Institute of Pathology, Section for Molecular Chemoresistance, Rikshospitalet-Radiumhospitalet HF, Oslo, Norway
Hypothesis
The study aims to determine potential differential responses to 8 and 24-hour 5-FU treatment in 5-FU-resistant colon cancer cell lines.
Conclusion
The study suggests that altered regulation of nucleotide metabolism, amino acid metabolism, cytoskeleton organization, transport, and oxygen metabolism may underlie the differential resistance to 5-FU seen in these cell lines.
Supporting Evidence
- 5-FU treatment for 24 hours resulted in S phase arrests and apoptosis induction in the parental and resistant cell lines.
- The strongly 5-FU-resistant ContinD cell line had the smallest S phase arrests and the lowest levels of 5-FU-induced apoptosis.
- The moderately 5-FU-resistant ContinB cell line had comparatively lower apoptotic levels than the parental cells.
Takeaway
Researchers looked at how two types of colon cancer cells that resist a drug called 5-FU respond to that drug. They found that these cells behave differently and might be using different ways to survive.
Methodology
The study assessed levels of 5-FU uptake into DNA, cell cycle effects, and apoptosis induction throughout treatment and recovery periods for each cell line.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website